| Financial Year |
March 31 2023 |
| Monetary Funds |
1,911,560,326.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
154,699,736.18 |
| Accounts Receivable |
2,140,311,897.74 |
| Advances to Suppliers |
8,972,290,254.99 |
| Other Receivables |
77,403,584.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,642,307,090.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,590,144.34 |
| Total Current Assets |
16,179,053,941.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
78,906,942.13 |
| Investment Properties |
28,409,500.00 |
| Fixed Assetes |
162,987,214.42 |
| Under-construction Projects |
156,173,699.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,438,178.77 |
| R&D expenses |
-- |
| Goodwill |
35,961,839.97 |
| Long-Term Deferred and Prepaid Expenses |
4,695,645.84 |
| Deferred Income Tax Assets |
67,050,317.63 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
622,599,835.49 |
| Total Assets |
16,801,653,776.51 |
| Short-Term Loans |
2,690,566,823.12 |
| Trading Financial liabilities |
603,280.00 |
| Notes Payable |
711,970,006.65 |
| Accounts Payable |
141,836,039.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,425,815.85 |
| Taxes Payable |
50,078,435.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
702,127,662.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,630,698.95 |
| Other Current Liabilities |
1,855,337,306.82 |
| Sub-Total of Current Liabilities |
12,672,111,346.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,863,427.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,118,566.03 |
| Total Liabilities |
12,708,229,912.75 |
| Paid-In Capital(Or Share Stock) |
268,184,597.00 |
| Capital Surplus |
792,221,658.01 |
| Surplus Reserve |
71,769,182.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
722,179,365.86 |
| Minority Stockholder's Interest |
2,252,282,663.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,841,141,200.01 |
| Owner's Equity（Stockholder's Equity） |
4,093,423,863.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,801,653,776.51 |
